- Suchergebnis für K00720
Cookie-Einstellungen
Diese Website benutzt Cookies, die für den technischen Betrieb der Website erforderlich sind und stets gesetzt werden. Andere Cookies, die den Komfort bei Benutzung dieser Website erhöhen, der Direktwerbung dienen oder die Interaktion mit anderen Websites und sozialen Netzwerken vereinfachen sollen, werden nur mit Ihrer Zustimmung gesetzt.
Konfiguration
Technisch erforderlich
Diese Cookies sind für die Grundfunktionen des Shops notwendig.
"Alle Cookies ablehnen" Cookie
"Alle Cookies annehmen" Cookie
Ausgewählter Shop
CSRF-Token
Cookie-Einstellungen
FACT-Finder Tracking
Individuelle Preise
Kundenspezifisches Caching
Session
Währungswechsel
Komfortfunktionen
Diese Cookies werden genutzt um das Einkaufserlebnis noch ansprechender zu gestalten, beispielsweise für die Wiedererkennung des Besuchers.
Facebook-Seite in der rechten Blog - Sidebar anzeigen
Merkzettel
Statistik & Tracking
Endgeräteerkennung
Kauf- und Surfverhalten mit Google Tag Manager
Partnerprogramm
Zu "K00720" wurden 46 Artikel gefunden!
Filter schließen
Filtern nach:
Für die Filterung wurden keine Ergebnisse gefunden!
Artikelnummer: Cay17236-5
DL-threo-PPMP is a ceramide analog and an inhibitor of glucosylceramide synthase. It inhibits glucosylceramide synthase by 70, 41, and 62% in MDCK cell homogenates, mouse liver microsomes, and mouse brain homogenates, respectively, when used at a concentration of 20 µM. DL-threo-PPMP also inhibits sphingomyelin...
Schlagworte: | DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol,... |
Anwendung: | Glucosylceramide synthase inhibitor |
CAS | 139974-41-7 |
MW: | 511.2 D |
ab 54,00 €
Artikelnummer: TGM-T35626-100mg
Description: AMP-Deoxynojirimycin (AMP-DNM) is a potent inhibitor of ceramide glucosyltransferase and GCase 2, as well as GlcCer biosynthesis, and is utilized in the study of Parkinson's disease and diabetes. Target: Glucosidase, Transferase. Smiles:...
Schlagworte: | AMP-DNM |
Anwendung: | Glucosylceramide synthase inhibitor |
CAS | 216758-20-2 |
MW: | 397.55 D |
ab 96,00 €
Artikelnummer: TGM-T36581-1mg
Description: Glucocerebrosides is a natural product. Target: Others. References: Sperling P, et al. Are glucocerebrosides the predominant sphingolipids in plant plasma membranes? Plant Physiol Biochem. 2005 Dec,43(12):1031-8.
Anwendung: | Glucocerebroside mixture |
CAS | 497155-61-0 |
96,00 €
Artikelnummer: TGM-T36582-10mg
Description: Glucocerebrosides are formed by the tethering of glucose to a ceramide by glucosylceramide synthase. They are present in neuronal and non-neuronal mammalian tissues and are found at low quantities in a large number of plant species. Glucocerebrosides are precursors in the synthesis of lactosylceramides...
Anwendung: | Lactosylceramide & ganglioside precursor |
CAS | 85305-87-9 |
MW: | 812.3 D |
ab 181,00 €
Artikelnummer: TGM-T3663-100mg
Description: Eliglustat (Genz 99067) is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease. Target: Transferase. Smiles: CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1. References: Shayman JA. Drugs Future. 2010, 35(8):613-620.
Schlagworte: | Genz 99067, GENZ-112638 |
Anwendung: | Targets ceramide glucosyltransferase [EC:2.4.1.80] (UGCG) |
CAS | 491833-29-5 |
MW: | 404.54 D |
ab 52,00 €
Artikelnummer: TGM-T38822-5mg
Description: D-threo-PPMP, a powerful glucosylceramide (GlcCer) synthase inhibitor, effectively impedes karyokinesis and decreases cyst formation. Target: Others. Smiles: CCCCCCCCCC CCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1. References: Gouazé V, et, al. Glucosylceramide synthase blockade down-regulates...
Anwendung: | Glucosylceramide synthase inhibitor control (inactive) |
CAS | 139889-53-5 |
MW: | 474.73 D |
951,00 €
Artikelnummer: TGM-T39478-5mg
Description: L-threo-PPMP is an inhibitor of GlcT, which is the UDP-Glc: Ceramide beta1,1glucosyltransferase enzyme. It effectively inhibits glycosphingolipid biosynthesis, while also inducing apoptosis. These properties of L-threo-PPMP contribute to its notable anti-cancer activity. Target: Others. Smiles:...
Anwendung: | Glucosylceramide synthase inhibitor control (inactive) |
CAS | 207278-87-3 |
MW: | 474.73 D |
951,00 €
Artikelnummer: TGM-T36974-10mg
Description: D-threo-PPMP is a glucosylceramide (GlyCer) synthetase inhibitor.1,2It is the active enanantiomer and enzymatic inhibitory component of the racemic DL-threo-PPMP . In MDCK kidney epithelial cells, D-threo-PPMP induces a 70% reduction in cell growthin vitroat 20 µM and significantly inhibits DNA...
Anwendung: | Glucosylceramide (GlyCer) synthetase inhibitor |
CAS | 139889-65-9 |
MW: | 511.19 D |
ab 514,00 €
Artikelnummer: TGM-T37551-10mg
Description: (+)-D-threo-PDMP is a ceramide analog and is one of the four possible stereoisomers of PDMP . (+)-D-threo-PDMP is an inhibitor of glucosylceramide synthase. It inhibits glucosylceramide synthase by 50% when used at a concentration of 5 µM in an enzyme assay. (+)-D-threo-PDMP is the active component of...
Anwendung: | Glucosylceramide (GlyCer) synthetase inhibitor |
CAS | 139889-62-6 |
MW: | 427.03 D |
1.147,00 €
Artikelnummer: TGM-T38489-5mg
Description: D,L-erythro-PDMP, an erythro isomer of PDMP, exhibits growth inhibition on cultured rabbit skin fibroblasts. Additionally, this compound serves as an effective inhibitor of UDP-glucose: ceramide glucosyltransferase. Target: Others. Smiles: CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@@H](O)c1ccccc1. References:...
Anwendung: | Cell growth inhibitor |
CAS | 109760-77-2 |
MW: | 390.568 D |
951,00 €
Artikelnummer: TGM-T4049-100mg
Description: Genz 123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1. Target: Glucokinase. Smiles: CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1. References: Zhao H, et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal...
Anwendung: | Glucosylceramide synthase (ceramide glucosyltransferase) inhibitor |
CAS | 491833-30-8 |
MW: | 418.57 D |
ab 43,00 €
Artikelnummer: TGM-T4473-100mg
Description: Ibiglustat (GZ402671) is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. Ibiglustat blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthesis of GL-3. Ibiglustat is potentially useful for treating Fabry disease. Fabry...
Schlagworte: | Venglustat, SAR402671, GZ402671 |
Anwendung: | Targets ceramide glucosyltransferase [EC:2.4.1.80] (UGCG) |
CAS | 1401090-53-6 |
MW: | 389.49 D |
ab 54,00 €